Similar to the behavior of before mentioned inflammation-associated rare cells, the CD44+ CRC also showed what we have referred to as multi-pathology association (Schreier and Triampo 2021a) which, in consequence translates into a low specificity towards cancer. Here, CD44 is linked to colorectal carcinoma.